GlassScriptPhysician profile
Qing Ruan
NPI 1326447269
$5,598.18
in general payments reported to CMS, 2019-2025
10 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,454 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,098 · Food and Beverage: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,097.87 |
| Food and Beverage | $1,500.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $2,331.73 | 2024 | Reactiv8 |
| Abbott Laboratories | $1,637.83 | 2024-2025 | Proclaim, Eterna, Infinity |
| Boston Scientific Corporation | $826.74 | 2024 | |
| Medtronic, INC. | $188.28 | 2024 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $137.11 | 2024 | Sprint Pns System |
| Curonix LLC | $122.59 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.40 | 2024 | Relistor |
| Vertos Medical, INC. | $116.02 | 2024 | Mild Device Kit |
| Painteq LLC | $105.83 | 2024 | Painteq |
| Stryker Corporation | $13.65 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qing Ruan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.